BIOMAT Database Logo BIOMAT Database Logo

Comparison of pharmacokinetics between CsA capsules and Sandimmun Neoral in pediatric patients. 1994

C Y Lin, and S F Lee
Department of Pediatrics and Pharmaceutics, Veterans General Hospital-Taipei, Taiwan, Republic of China.

UI MeSH Term Description Entries
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic

Related Publications

C Y Lin, and S F Lee
Use of Sandimmun Neoral in renal transplant patients. International Sandimmun Neoral Study Group.
October 1994, Transplantation proceedings,
C Y Lin, and S F Lee
[Sandimmun vs Neoral, comparison between two types of cyclosporine in patients with kidney transplantation].
January 2000, Revista medica de Panama,
C Y Lin, and S F Lee
Sandimmun neoral pharmacokinetics: impact of the new oral formulation.
February 1995, Transplantation proceedings,
C Y Lin, and S F Lee
Pharmacokinetics of cyclosporine in pediatric long-term liver transplant recipients converted from Sandimmun to Neoral.
January 1997, Transplant international : official journal of the European Society for Organ Transplantation,
C Y Lin, and S F Lee
Advertising of "Sandimmun Neoral".
February 1999, Lancet (London, England),
C Y Lin, and S F Lee
The pharmacokinetics of Sandimmun Neoral: a new oral formulation of cyclosporine.
October 1994, Transplantation proceedings,
C Y Lin, and S F Lee
Sandimmun-to-Neoral conversion in stable pediatric kidney transplant recipients.
August 1998, Transplantation proceedings,
C Y Lin, and S F Lee
Cyclosporine pharmacokinetics in stable renal transplant patients: effect of formulation Sandimmun versus Consupren versus Neoral.
June 1996, Transplantation proceedings,
C Y Lin, and S F Lee
Conversion from Sandimmun to Neoral in stable pediatric renal transplant recipients.
April 1998, Pediatric nephrology (Berlin, Germany),
C Y Lin, and S F Lee
The Swedish nationwide experience of converting transplant patients treated with Sandimmun to the new galenic formulation Sandimmun-neoral. The Swedish Sandimmun-Neoral Conversion Group.
January 1997, Transplantation proceedings,
Copied contents to your clipboard!